Tatva Chintan Pharma Chem Faces Declining Profitability Amidst Market Challenges

Jun 10 2025 08:56 AM IST
share
Share Via
Tatva Chintan Pharma Chem has recently experienced a change in evaluation, indicating a shift in its technical trend. The company faces significant financial challenges, including a notable decline in operating profit and a low return on capital employed. Institutional investor participation has also decreased, reflecting broader market difficulties.
Tatva Chintan Pharma Chem, a small-cap player in the specialty chemicals industry, has recently undergone an adjustment in evaluation. This revision reflects a shift in the technical trend, moving from a mildly bearish stance to a sideways position.

Key financial metrics indicate a challenging landscape for the company. Over the past five years, operating profit has contracted at an annual rate of 42.27%. The latest quarter's performance shows a significant decline, with profit after tax (PAT) at Rs 1.17 crore, down by 91.05%. Additionally, the return on capital employed (ROCE) stands at a low of 1.14%, while the return on equity (ROE) is recorded at 0.8.

The stock has also faced consistent underperformance against the benchmark, generating a return of -5.13% over the past year. Institutional investor participation has waned, with a decrease in their stake by 0.94% in the last quarter, now holding 8.76% of the company.

Overall, the technical indicators suggest a lack of clear price momentum, reflecting the broader challenges faced by Tatva Chintan Pharma Chem in the current market environment.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News